ABLIM2 Knockout Huh-7 Polyclonal Cells are a CRISPR/Cas9-edited polyclonal knockout cell population designed to disrupt the ABLIM2 gene in the Huh-7 hepatocellular carcinoma cell line. The polyclonal format comprises a heterogeneous pool of cells with varied editing outcomes, providing a bulk loss-of-function model suitable for population-level analyses. This product enables investigation of ABLIM2-dependent processes without the bias of clonal selection, offering a versatile platform for liver cancer research.
The Huh-7 cell line is a well-differentiated human hepatocellular carcinoma model derived from liver epithelial cells. It retains hepatocyte-like properties and is widely used in studies of liver cancer biology, drug metabolism, and viral hepatitis. Its well-differentiated state, including robust cell?Ccell junctions and polarized morphology, makes Huh-7 an ideal host for examining cytoskeletal and adhesion dynamics. This background provides a physiologically relevant context for exploring ABLIM2 function in hepatocellular carcinoma progression and metastasis.
ABLIM2 encodes an actin-binding LIM domain protein central to cytoskeletal organization and cell adhesion. It interacts directly with filamentous actin and LIM domain proteins, acting downstream of mechanical stress and Rho GTPase signals. ABLIM2 regulates actin filament assembly and stabilizes focal adhesion complexes through pathways involving integrins and focal adhesion kinase (FAK). By modulating actin dynamics, ABLIM2 influences cell morphology, migration, and substrate attachment, serving as a key mediator of mechanical signal transduction.
Knockout of ABLIM2 in Huh-7 cells is expected to disrupt actin cytoskeletal remodeling and focal adhesion turnover, altering cell migration, invasion, and metastatic potential. The well-differentiated nature of Huh-7 cells allows dissection of ABLIM2??s role in epithelial integrity, collective migration, and mechanical responses within the tumor microenvironment. The polyclonal population mimics heterogeneous gene inactivation found in tumors, offering insights into phenotypic variability. This model is particularly valuable for studying how ABLIM2-mediated adhesion contributes to liver cancer invasiveness.
Typical research applications include hepatocellular carcinoma biology, actin cytoskeleton dynamics, tumor migration and invasion, and drug resistance mechanisms. Standard phenotypic assays include western blotting, immunofluorescence, phalloidin staining, wound healing, and transwell invasion. These cells can also be used in high-content screening for modifiers of ABLIM2-related phenotypes. For further information, please contact Ascent Research.
